|
|
Article: GENENTECH FILES SUIT AGAINST GENZYME OVER TNKASE PATENT.
- Article from:
- BIOWORLD Today
- Article date:
- March 16, 2001
- Author:
CopyrightCOPYRIGHT 2001 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Genentech Inc. filed suit against Genzyme Corp. in U.S. District Court in Delaware in a patent/contract dispute related to TNKase (tenecteplase).
Sabrina Johnson, Genentech's director of corporate communications, confirmed that the company had filed a lawsuit, and added that Genentech is "looking forward to getting this resolved with Genzyme," but said the company would make no further comment concerning the case.
The case relates to U.S. Patent No. 5,344,733 held by Genzyme and licensed about 10 years ago to Genentech, said Caroline Copithorne, an analyst at Morgan Stanley Dean Witter in San Francisco. "The thing that seems odd is that Genentech ...
Related newspaper, magazine, and journal articles:
|
|
Article: EquityOutlook.Com announces stock evaluation ratings for ...
M2 Presswire;
May 28, 2003 ;
700+ words
... ... EquityOutlook.Com announces stock evaluation ratings for Genentech, IBM, Genzyme General, Sara Lee Corporation, Electronic Arts ... makes these short-term stock recommendations: Genentech (NYSE:DNA - News) - WEAK BUYIBM (NYSE:IBM ...
|
|